Opioid Maker Says It Won't Market In Doctors' Offices Anymore
Purdue Pharma has cut its sales staff in half.
A drugmaker says it will no longer market its opioid products in doctors' offices after facing backlash for the way the industry promotes the addictive drugs.
OxyContin maker Purdue Pharma said it will tell doctors about its decision Monday. As part of the plan, the company has cut its sales force in half.
Opioids killed more than 42,000 people in 2016 according to the Centers for Disease Control and Prevention, and 40 percent of those deaths involved a prescription opioid.
Doctors who want information on opioids will now need to contact the company's medical affairs department.
Life-saving drugs cost thousands in the US. Can laws change that?
Prescription drugs are often priced higher in the U.S. than in other countries, but there is legislation that aims to cut costs.By AP
The science and safety behind newly popular weight loss drugs
Today’s weight loss drugs pull from the science of diabetes treatments. Those have been proven for years to have fewer and less serious side effects.By Patrick Sison / AP
Amazon launches $5-a-month unlimited prescriptions for Prime members
The retail giant’s RxPass has a prescription list that includes more than 50 common medications.By Mark Lennihan / AP
GOP on State of the Union: 'Biden and the Democrats have failed you'
Arkansas Gov. Sarah Huckabee Sanders told her audience that Biden and the Democratic Party “failed you. You know it, and they know it.”By Al Drago / AP
After State of the Union, Tyre Nichols' family pushes accountability
Just after attending the State of the Union address, Tyre Nichols' parents talked to Scripps News about their experience and hopes for the future.By Patrick Semansky / AP
President Joe Biden delivers the 2023 State of the Union address
President Joe Biden's annual address focused on bipartisanship while touting the administration’s economic accomplishments.By Patrick Semansky / AP